Humana 2014 Annual Report Download - page 116

Download and view the complete annual report

Please find page 116 of the 2014 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 158

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158

Humana Inc.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
108
Credit Agreement
Our 5-year $1.0 billion unsecured revolving credit agreement expires July 2018. Under the credit agreement, at
our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit
portion bears interest at either LIBOR plus a spread or the base rate plus a spread. The LIBOR spread, currently 110
basis points, varies depending on our credit ratings ranging from 90 to 150 basis points. We also pay an annual facility
fee regardless of utilization. This facility fee, currently 15 basis points, may fluctuate between 10 and 25 basis points,
depending upon our credit ratings. The competitive advance portion of any borrowings will bear interest at market rates
prevailing at the time of borrowing on either a fixed rate or a floating rate based on LIBOR, at our option.
The terms of the credit agreement include standard provisions related to conditions of borrowing, including a
customary material adverse effect clause which could limit our ability to borrow additional funds. In addition, the credit
agreement contains customary restrictive and financial covenants as well as customary events of default, including
financial covenants regarding the maintenance of a minimum level of net worth of $7.8 billion at December 31, 2014
and a maximum leverage ratio of 3.0:1. We are in compliance with the financial covenants, with actual net worth of
$9.6 billion and actual leverage ratio of 1.4:1, as measured in accordance with the credit agreement as of December 31,
2014. In addition, the credit agreement includes an uncommitted $250 million incremental loan facility.
At December 31, 2014, we had no borrowings outstanding under the credit agreement. We have outstanding letters
of credit of $4 million issued under the credit agreement at December 31, 2014. No amounts have been drawn on these
letters of credit. Accordingly, as of December 31, 2014, we had $996 million of remaining borrowing capacity under
the credit agreement, none of which would be restricted by our financial covenant compliance requirement. We have
other customary, arms-length relationships, including financial advisory and banking, with some parties to the credit
agreement.
Commercial Paper
In October 2014, we entered into a commercial paper program pursuant to which we may issue short-term, unsecured
commercial paper notes privately placed on a discount basis through certain broker dealers. Amounts available under
the program may be borrowed, repaid and re-borrowed from time to time, with the aggregate face or principal amounts
outstanding under the program at any time not to exceed $1 billion. The net proceeds of issuances have been and are
expected to be used for general corporate purposes, including to repurchase shares of our common stock. The maximum
principal amount of commercial paper borrowings outstanding at any one time during the year ended December 31,
2014 was $175 million. There were no outstanding borrowings at December 31, 2014.
13. EMPLOYEE BENEFIT PLANS
Employee Savings Plan
We have defined contribution retirement savings plans covering eligible employees which include matching
contributions based on the amount of our employees’ contributions to the plans. The cost of these plans amounted to
approximately $176 million in 2014, $155 million in 2013, and $138 million in 2012, all of which was funded currently
to the extent it was deductible for federal income tax purposes. The Company’s cash match is invested pursuant to the
participant’s contribution direction. Based on the closing price of our common stock of $143.63 on December 31, 2014,
approximately 13% of the retirement and savings plan’s assets were invested in our common stock, or approximately
2.8 million shares, representing 2% of the shares outstanding as of December 31, 2014. At December 31, 2014,
approximately 4.1 million shares of our common stock were reserved for issuance under our defined contribution
retirement savings plans.